Feb 28, 2025· Comment from Association for Accessible Medicines (AAM)· FDA-2024-D-5601-0009
Association for Accessible Medicines (AAM) comment letter: E6(R3) Good Clinical Practice: Annex 2; ICH Draft Guidance for Industry
FDANonrulemakingFDA-2024-D-5601
E6(R3) Good Clinical Practice: Annex 2; International Council for Harmonisation; Draft Guidance for Industry; Availability
RIN
—
Last modified
Mar 13, 2025
Comment window
closed 484d ago
Association for Accessible Medicines filings
1
Activity
Association for Accessible Medicines filed 1 comment on this docket between Feb 28, 2025 and Feb 28, 2025. 0 other organizations filed here. The comment window closed 484d ago.
What Association for Accessible Medicines filed (1)
Abstract
OPEN
View on regulations.gov →Co-filers (0)
See everyone who commented →- Association for Accessible MedicinesTHIS ORG1 filing · confidence 97%